A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 50 shares of AMGN stock, worth $13,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50
Previous 50 -0.0%
Holding current value
$13,916
Previous $15,000 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $16,219 - $21,511
-89 Reduced 64.03%
50 $10,000
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $17,411 - $20,862
-100 Reduced 41.84%
139 $27,000
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $8,302 - $9,325
50 Added 26.46%
239 $44,000
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $337 - $377
-2 Reduced 1.05%
189 $33,000
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $31,952 - $36,481
191
191 $36,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.